Mid-Market M&A Picks Up as Private Equity Returns to the Table
Dry powder, steadier financing and patient sellers are reviving deal flow below the billion-dollar mark.
Saturday, September 26, 2026
Sections
More coverage
criminalmindscast.com
Category
Deals, due diligence and the legal side of M&A.
Dry powder, steadier financing and patient sellers are reviving deal flow below the billion-dollar mark.
Vague accounting definitions and buyer discretion are the usual culprits. Clauses that keep earn-outs out of court.
Longer outside dates, reverse termination fees and early engagement with regulators are now standard planning tools.
Financial statement and compliance breaches drive most claims. What buyers can do before signing to protect recovery.
Machine review speeds up the data room, but judgement calls on culture, litigation and key contracts still need people.
Deals once waved through are now examined for effects on innovation and data. Planning for review from day one.
Buyers rarely win a walk-away argument, but the threat still shapes renegotiations. What courts look for.
More countries now review foreign buyers in sensitive sectors. How to map filings and avoid a late-stage surprise.
Contract consents, employee transfers and data migration can undo value if nobody owns them after closing.
Activists push for sales, break-ups and better terms. How boards prepare before the first letter arrives.